Forty-third ECDD documents

The forty-third meeting of the Expert Committee on Drug Dependence (ECDD) was held in Geneva, Switzerland from 12-16 October 2020.

Please find the meeting documents on this page. For more information, please do not hesitate to contact the Secretariat at: ecddsecretariat@who.int

 

Substances for review

The substances listed below have never been formally reviewed by WHO and are not currently under international control.  Information was brought to WHO’s attention that these substances are clandestinely manufactured, of especially serious risk to public health and society, and of no recognised therapeutic use by any Party.

Technical documents

Synthetic opioids

Critical review:

Isotonitazene

Synthetic cannabinoid receptor agonists

Critical review:

MDMB-4en-PINACA

CUMYL-PEGACLONE

Benzodiazepines

Critical review:

Flubromazolam

Clonazolam

Diclazepam

Dissociative-type substances

Critical review:

3-MeO-PCP

DIPHENIDINE

2-MEO-DIPHENIDINE

Hallucinogen

Critical review:

5-MEO-DALT

Synthetic stimulant

Critical review:

3-FLUOROPHENMETRAZINE (3-FPM)